CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication - Xconomy

CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication - Xconomy: "

CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication Xconomy CoDa says it plans to use the new venture capital to run large, mid-stage trial to confirm the result at multiple medical centers in the US, Australia, and New Zealand. CoDa has a few well-known names on its board. The group includes Jim Blair of ... and more »

"